IOCB have participated in many drug development and chemical technology  projects and many compounds originated from IOCB reached a market. By now, only several projects were decided to be commercialised as a spin-off companies. Some projects based on IOCB compounds failed for various reasons before or after a company formation, but beside that some are under way or  in preparation. The company Okapi sciences Inc., an innovative veterinanry medicine company, which was co-founded by IOCB was succesfuly aquired by Aratana Therapeutics Inc. in Jan 2014. This aquisition will help to exploit compounds and know-how from IOCB to improve treatment possibilities for animal virus infections either for pets or farmed animals.